Lenacapavir rollout in Kenya shows minimal side effects, with only mild injection pain reported. [File Courtesy]
No major adverse effects have been reported since the rollout of the long-acting HIV prevention injection, Lenacapavir, a month ago.
The main side effect is mild pain at the injection site, which subsides within two to three days.
Facts First
This story continues on The Standard INSiDER. Subscribe now for unfiltered journalism that holds power to account.
Already have an account? Login
The Standard Group Plc is a multi-media organization with investments in media
platforms spanning newspaper print
operations, television, radio broadcasting, digital and online services. The
Standard Group is recognized as a
leading multi-media house in Kenya with a key influence in matters of national
and international interest.